Tnf Pharmaceuticals, Stock Current Liabilities

TNFA Stock   1.29  0.07  5.15%   
TNF Pharmaceuticals, fundamentals help investors to digest information that contributes to TNF Pharmaceuticals,'s financial success or failures. It also enables traders to predict the movement of TNF Stock. The fundamental analysis module provides a way to measure TNF Pharmaceuticals,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TNF Pharmaceuticals, stock.
As of December 23, 2024, Total Current Liabilities is expected to decline to about 3 M. In addition to that, Non Current Liabilities Total is expected to decline to about 95.5 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TNF Pharmaceuticals, Company Current Liabilities Analysis

TNF Pharmaceuticals,'s Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

TNF Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for TNF Pharmaceuticals, is extremely important. It helps to project a fair market value of TNF Stock properly, considering its historical fundamentals such as Current Liabilities. Since TNF Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TNF Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TNF Pharmaceuticals,'s interrelated accounts and indicators.
1.0-0.99-0.97-0.89-0.920.650.98-0.57-0.890.651.0-0.27-0.630.980.91
1.0-0.99-0.95-0.87-0.950.650.99-0.64-0.850.650.99-0.21-0.580.960.92
-0.99-0.990.920.830.94-0.73-1.00.640.82-0.73-0.980.150.52-0.95-0.93
-0.97-0.950.920.980.81-0.54-0.910.370.97-0.54-0.980.50.81-0.99-0.84
-0.89-0.870.830.980.7-0.39-0.810.220.99-0.39-0.920.660.91-0.96-0.74
-0.92-0.950.940.810.7-0.63-0.950.830.67-0.63-0.89-0.030.35-0.84-0.88
0.650.65-0.73-0.54-0.39-0.630.76-0.6-0.451.00.660.09-0.140.620.87
0.980.99-1.0-0.91-0.81-0.950.76-0.67-0.810.760.97-0.13-0.50.940.95
-0.57-0.640.640.370.220.83-0.6-0.670.2-0.6-0.52-0.43-0.15-0.44-0.69
-0.89-0.850.820.970.990.67-0.45-0.810.2-0.45-0.920.680.91-0.96-0.76
0.650.65-0.73-0.54-0.39-0.631.00.76-0.6-0.450.660.09-0.140.620.87
1.00.99-0.98-0.98-0.92-0.890.660.97-0.52-0.920.66-0.34-0.680.990.91
-0.27-0.210.150.50.66-0.030.09-0.13-0.430.680.09-0.340.91-0.45-0.18
-0.63-0.580.520.810.910.35-0.14-0.5-0.150.91-0.14-0.680.91-0.76-0.48
0.980.96-0.95-0.99-0.96-0.840.620.94-0.44-0.960.620.99-0.45-0.760.89
0.910.92-0.93-0.84-0.74-0.880.870.95-0.69-0.760.870.91-0.18-0.480.89
Click cells to compare fundamentals

TNF Current Liabilities Historical Pattern

Today, most investors in TNF Pharmaceuticals, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various TNF Pharmaceuticals,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of TNF Pharmaceuticals, current liabilities as a starting point in their analysis.
   TNF Pharmaceuticals, Current Liabilities   
       Timeline  
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

TNF Total Current Liabilities

Total Current Liabilities

3.04 Million

At present, TNF Pharmaceuticals,'s Total Current Liabilities is projected to increase significantly based on the last few years of reporting.
In accordance with the recently published financial statements, TNF Pharmaceuticals, has a Current Liabilities of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.

TNF Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TNF Pharmaceuticals,'s direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics of similar companies.
TNF Pharmaceuticals, is currently under evaluation in current liabilities category among its peers.

TNF Pharmaceuticals, Current Valuation Drivers

We derive many important indicators used in calculating different scores of TNF Pharmaceuticals, from analyzing TNF Pharmaceuticals,'s financial statements. These drivers represent accounts that assess TNF Pharmaceuticals,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TNF Pharmaceuticals,'s important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap19.5K224.5K2.2M2.5M2.9M3.1M
Enterprise Value507.0K(14.3M)1.8M1.9M313.9K329.6K

TNF Fundamentals

About TNF Pharmaceuticals, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:
Check out TNF Pharmaceuticals, Piotroski F Score and TNF Pharmaceuticals, Altman Z Score analysis.
For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.48)
Return On Assets
(0.32)
Return On Equity
(2.98)
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.